Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

A ‘replace me’ signal from dying brown fat fires up weight loss

Brown fat in the body converts energy into heat. The discovery that inosine molecules are released from dying brown fat and induce heat production in nearby brown fat cells could point to a way of combating obesity.
  1. Katrien De Bock

    1. Katrien De Bock is in the Department of Health Sciences and Technology, ETH Zurich, Zurich 8603, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Christian Wolfrum

    1. Christian Wolfrum is in the Department of Health Sciences and Technology, ETH Zurich, Zurich 8603, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Almost 60% of adults and nearly one-third of children in Europe are overweight or obese (see go.nature.com/3bsIjrd). Beyond lifestyle interventions, effective therapies to reduce obesity mostly involve surgery, so new, less-invasive strategies are required. A type of fat known as brown adipose tissue (BAT) is currently the subject of interest as a target for weight-loss intervention, because it burns calories by releasing stored energy in organelles called mitochondria and converting it to heat — a process called thermogenesis1,2. Evidence indicates that the activity of BAT is associated with reduced weight and improved metabolic health1. Writing in Nature, Niemann et al.3 outline a previously unknown regulatory pathway governing the activity of BAT that could potentially be targeted for therapeutic weight loss.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Nature 609, 252-253 (2022)

doi: https://doi.org/10.1038/d41586-022-01826-5

References

  1. Becher, T. et al. Nature Med. 27, 58–65 (2021).

    Article  PubMed  Google Scholar 

  2. Sun, W., Modica, S., Dong, H. & Wolfrum, C. Nature Metab. 3, 751–761 (2021).

    Article  PubMed  Google Scholar 

  3. Niemann, B. et al. Nature 609, 361–368 (2022).

    Article  PubMed  Google Scholar 

  4. Schulz, T. J. et al. Nature 495, 379–383 (2013).

    Article  PubMed  Google Scholar 

  5. Shi, Q. et al. Lancet 399, 259–269 (2022).

    Article  PubMed  Google Scholar 

  6. Carpentier, A. C., Blondin, D. P., Haman, F. & Richard, D. Endocr. Rev. https://doi.org/10.1210/endrev/bnac015 (2022).

    Article  Google Scholar 

  7. Wolfrum, C. & Gerhart-Hines, Z. Science 375, 1229–1231 (2022).

    Article  PubMed  Google Scholar 

  8. Pontzer, H. et al. Science 373, 808–812 (2021).

    Article  PubMed  Google Scholar 

  9. Shabalina, I. G., Jacobsson, A., Cannon, B. & Nedergaard, J. J. Biol. Chem. 279, 38236–38248 (2004).

    Article  PubMed  Google Scholar 

  10. Allard, B., Allard, D., Buisseret, L. & Stagg, J. Nature Rev. Clin. Oncol. 17, 611–629 (2020).

    Article  PubMed  Google Scholar 

  11. Boknik, P. et al. Front. Pharmacol. 11, 627838 (2021).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

The authors declare no competing interests.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links